2018 AGDF Program - Cover2
NO GENERIC ADEQUAN
The ONLY FDA approved equine PSGAG for the intramuscular treatment of non-infectious degenerative
joint disease (DJD) of the carpal and hock joints proven to:
* DIMINISH the destructive processes of degenerative joint disease
* REVERSE the processes which result in the loss of cartilage components
* IMPROVE overall joint function and associated lameness
Available for order! For more information about equine joint health and treatment with Adequan® i.m.,
please visit www.adequan.com.
For the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the
carpal and hock joints in horses.
IMPORTANT SAFETY INFORMATION
There are no known contraindications to the use of intramuscular Adequan® i.m. brand Polysulfated Glycosaminoglycan in horses.
Studies have not been conducted to establish safety in breeding horses. WARNING: Do not use in horses intended for human
consumption. Not for use in humans. Keep this and all medications out of the reach of children. CAUTION: Federal law restricts this
drug to use by or on the order of a licensed veterinarian.
Please see Full Prescribing Information at www.adequan.com.
Adequan® and the Horse Head design are registered trademarks of Luitpold Pharmaceuticals, Inc.
© Luitpold Animal Health, division of Luitpold Pharmaceuticals, Inc. 2017. PP-AI-US-0057